US 10709728
Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
granted A61KA61K2300/00A61K31/7115
Quick answer
US patent 10709728 (Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2300/00, A61K31/7115, A61K31/712, A61K31/7125